Advertisement

Internal and Emergency Medicine

, Volume 12, Issue 2, pp 143–145 | Cite as

Cardiac biomarkers of acute coronary syndrome: from history to high-sensitive cardiac troponin

  • Mario PlebaniEmail author
  • Giorgia Antonelli
  • Martina Zaninotto
IM - COMMENTARY

Acute coronary syndrome (CHD) represents a major cause of morbidity and mortality, accounting for more than 8 millions deaths in 2013 worldwide [1]. Nevertheless, the mortality associated with CHD has fallen steeply in the past few decades reflecting, at least in part, the shift in the pattern of acute coronary syndrome (ACS), with the rise in non-ST-segment elevation ACS (NSTE-ACS) and a decline in ST-segment elevation myocardial infarction (STEMI), the latter accounting for approximately one-third of all ACS events [2]. This shift in the last decade is basically due to a paradigmatic change in diagnostic testing with a widespread use of cardiac troponin assays, as well as to the change in the risk factor profile of patients with ACS [3]. Cardiac troponin [both troponin I (cTnI) and T (cTnT)] assay] has become globally recognized as the preferred biomarker for diagnosing ACS, replacing all other laboratory tests, including creatine kinase (CK), CK MB, and myoglobin for its “absolute”...

Keywords

Acute Coronary Syndrome Acute Myocardial Infarction Acute Myocardial Infarction Cardiac Troponin Elevation Acute Coronary Syndrome 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Notes

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Statement of human and animal rights

This article does not contain any studies with human participants or animals performed by any of the authors.

Informed consent

None.

References

  1. 1.
    Roth GA, Huffman MD, Moran AE et al (2015) Global and regional patterns in cardiovascular mortality from 1990 to 2013. Circulation 132:1667–1678CrossRefPubMedGoogle Scholar
  2. 2.
    Gupta A, Wang Y, Spertus A et al (2014) Trends in acute myocardial infarction in young patients and differences by sex and race, 2001 to 2010. J Am Coll Cardiol 64(4):337–345CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Eisen A, Giugliano RP, Braunwald E (2016) Updates on acute coronary syndrome. A review. JAMA Cardiol 1:718–730CrossRefPubMedGoogle Scholar
  4. 4.
    Brush JE Jr, Kaul S, Krumholz HM (2016) Troponin testing for clinicians. Am Coll Cardiol 68:2365–2375CrossRefGoogle Scholar
  5. 5.
    Zimmern RL (2009) Testing challenges: evaluation of novel diagnostics and molecular biomarkers. Clin Med 9:68–73CrossRefGoogle Scholar
  6. 6.
    Garg P, Morris P, Fazlanie AL, Vijayan S, Dancso B, Dastidar AG et al (2017) Cardiac biomarkers of acute coronary syndrome: from history to high-sensitivity cardiac troponin. Intern Emerg Med. doi: 10.1007/s11739-017-1612-1 PubMedGoogle Scholar
  7. 7.
    Casagranda I, Cavazza M, Clerico A, Galvani M, Ottani F, Zaninotto M et al (2013) Proposal for the use in emergency departments of cardiac troponins measured with the latest generation methods in patients with suspected acute coronary syndrome without persistent ST-segment elevation. Clin Chem Lab Med 51:1727–1737CrossRefPubMedGoogle Scholar
  8. 8.
    Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD (2012) Third universal definition of myocardial infarction. Circulation 126:2020–2035CrossRefPubMedGoogle Scholar
  9. 9.
    Sandoval Y, Apple FS (2014) The global need to define normality: the 99th percentile value of cardiac troponin. Clin Chem 60(3):455–462CrossRefPubMedGoogle Scholar
  10. 10.
    Shah AS, Griffiths M, Lee KK, McAllister DA, Hunter AL, Ferry AV et al (2015) High sensitivity cardiac troponin and the under-diagnosis of myocardial infarction in women: prospective cohort study. BMJ 21(350):g7873. doi: 10.1136/bmj.g7873 CrossRefGoogle Scholar
  11. 11.
    Shah AS, Anand A, Sandoval Y, Lee KK, Smith SW, Adamson PD et al (2015) High-STEACS investigators. High-sensitivity cardiac troponin I at presentation in patients with suspected acute coronary syndrome: a cohort study. Lancet 386:2481–2488CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Möckel M, Giannitsis E, Mueller C, Huber K, Jaffe AS, Mair J, Plebani M, Thygesen K, Lindahl B; Biomarker Study Group of the European Society of Cardiology Acute Cardiovascular Care Association (2016) Rule-in of acute myocardial infarction: focus on troponin. Eur Heart J Acute Cardiovasc Care. doi: 10.1177/2048872616653228
  13. 13.
    Body R, Mueller C, Giannitsis E, Christ M, Ordonez-Llanos J, de Filippi CR, TRAPID-AMI Investigators et al (2016) The use of very low concentrations of high-sensitivity troponin T to rule out acute myocardial infarction using a single blood test. Acad Emerg Med 23:1004–1013CrossRefPubMedGoogle Scholar
  14. 14.
    Mueller C, Giannitsis E, Christ M, Ordóñez-Llanos J, deFilippi C, McCord J, TRAPID-AMI Investigators et al (2016) Multicenter evaluation of a 0-hour/1-hour algorithm in the diagnosis of myocardial infarction with high-sensitivity cardiac troponin T. Ann Emerg Med 68(76–87):e4Google Scholar
  15. 15.
    Santi L, Farina G, Gramenzi A, Trevisani F, Baccini M, Bernardi M et al (2016) The HEART score with high-sensitive troponin T at presentation: ruling out patients with chest pain in the emergency room. Intern Emerg Med. doi: 10.1007/s11739-016-1461-3
  16. 16.
    Diez M, Talavera ML, Conde DG, Campos R, Acosta A, Trivi MS (2016) High-sensitivity troponin is associated with high risk clinical profile and outcome in acute heart failure. Cardiol J 23:78–83CrossRefPubMedGoogle Scholar
  17. 17.
    Thiruganasambandamoorthy V, Ramaekers R, Rahman MO, Stiell IG, Sikora L, Kelly S (2015) Prognostic value of cardiac biomarkers in the risk stratification of syncope: a systematic review. Intern Emerg Med 10:1003–1014CrossRefPubMedGoogle Scholar
  18. 18.
    Rostagno C, Cammilli A, Di Cristo A, Polidori GL, Ranalli C et al (2016) Acute coronary syndromes with significant troponin increase in patients with hip fracture prior to surgical repair: differential diagnosis and clinical implications. Intern Emerg Med 11(2):219–224. doi: 10.1007/s11739-015-1348-8 CrossRefPubMedGoogle Scholar

Copyright information

© SIMI 2017

Authors and Affiliations

  1. 1.Department of Laboratory MedicineUniversity-HospitalPaduaItaly

Personalised recommendations